DEFA14A: Mersana Therapeutics Sets Date for Annual Stockholder Meeting

Mersana Therapeutics announces its annual stockholder meeting to be held virtually on June 11, 2024, with voting open until June 10, 2024.

Summary

• Mersana Therapeutics will hold its Annual Meeting of Stockholders on June 11, 2024, at 9:00 AM ET.
• The meeting will be held virtually at www.virtualshareholdermeeting.com/MRSN2024.
• Stockholders can vote in advance of the meeting until June 10, 2024, at 11:59 PM ET via www.ProxyVote.com.
• The proxy materials, including the Notice of Annual Meeting, Proxy Statement, and Annual Report, are available online at www.ProxyVote.com.
• Stockholders can request a free paper or email copy of the materials before May 28, 2024.
• The voting items include the election of Class I Directors (Willard H. Dere, M.D. and Martin Huber, M.D.), an advisory vote on executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard procedural announcement.

Positives

• The meeting is being held virtually, providing convenient access for stockholders.
• Stockholders have multiple options for accessing proxy materials and voting.

Industry Context

This is a standard annual meeting announcement, a routine part of corporate governance for publicly traded companies.

Stakeholder Impact

• Shareholders are encouraged to vote on the proposals.
• The outcome of the votes will impact the company's governance and direction.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the virtual annual meeting on June 11, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Vote, Mersana Therapeutics, Directors, Ernst & Young, Virtual Meeting